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Background: miRNAs are involved in coordinating a variety of cellular processes by regulating their target genes.
Aberrant expression of miRNAs is correlated with various cancers. Previous studies have shown that miR-337 is
significantly down-regulated in pancreatic ductal adenocarcinoma (PDAC) and that its expression is negatively
correlated to the expression of HOXB7. Both miR-337 and HOXB7 are associated with the prognosis of PDAC
patients. The purpose of this study was to identify the molecular mechanisms by which miR-337 acts as a tumor
suppressor in PDAC.
Methods: Synthetic miR-337 mimics were transfected into PANC-1 and As-PC-1 cells using Lipofectamine™ 2000.
The expression of HOXB7 protein was analyzed by Western blot. Luciferase reporter plasmids were constructed to
confirm that HOXB7 3′UTR was the target of miR-337. The effect of miR-337 on cell proliferation was evaluated by
CCK8 assay and colony formation assay, and cell invasion was evaluated by wound healing assay and transwell assay.
Results: Western blot and luciferase activity assays identified HOXB7 as the target of miR-337. A CCK-8 assay showed
the absorbance of cells transfected with miR-337 mimics to be less than that of control cells, and that the number of
cell clones was significantly decreased by miR-337 expression. A wound healing assay showed the invasion rate of
cells transfected with miR-337 mimics at 36 h to be markedly lower than in controls. The average number of cells
penetrating the Matrigel was significantly lower than the controls.
Conclusion: These findings suggest that miR-337 targets HOXB7 and effects significant suppression of PDAC cell
proliferation and invasion.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
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microRNAs (miRNAs) are small non-coding, cellular
RNAs (17–27 bp) that function as sequence-specific
regulators of gene expression through translational re-
pression and transcript cleavage [1,2]. The discovery of
miRNAs and their mode of action revealed an entirely* Correspondence: ruizhang0001@126.com; zhaogq@zzu.edu.cn
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unless otherwise stated.new level of gene regulation. Many studies have shown
that miRNAs play key roles in cellular differentiation,
proliferation, and apoptosis [3–6]. Aberrant expression
of miRNAs has been found to be related to various hu-
man diseases, including cancers [7–9]. In cancerous tis-
sues, including pancreatic cancer tissues, microRNAs
appear to be dysregulated such that those with tumor-
suppressor activity are abrogated [10,11]. Those that are
overexpressed may function as oncogenes promoting
proliferation, migration and invasion and repressing
apoptosis [12,13].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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http://www.diagnosticpathology.org/content/9/1/171HOX genes belong to the superfamily of homeobox
genes and encode transcriptional factors that regulate
the expression of many downstream target genes.
Many studies have shown HOX genes to be highly
expressed in many cancers, such as breast cancer [14], ovar-
ian cancer [15], hepatocellular cancer [16], and leukemia
[17]. In addition, aberrant expression of HOX genes was
observed in pancreatic cancer [18]. During normal develop-
ment, HOXB7 stimulates the proliferation and survival of
progenitor cells. However, the over-expression of HOXB7
can markedly promote the transformation, proliferation,
and survival of tumor cells [19,20].
In previous studies, high levels of HOXB7 expression
and low levels of miR-337 were detected in human pan-
creatic ductal adenocarcinoma tissues (PDAC). The level
of HOXB7 mRNA in cancer was found to be negatively
correlated with the level of miR-337 [21]. The miRNA
miR-337 may repress tumor cell proliferation and metas-
tasis by targeting HOXB7. For this reason, the role of
miR-337 on HOXB7 expression and the effects of miR-
337 on proliferation and invasion in human pancreatic
cancer cells in vitro were here examined.
Materials and methods
Cell culture
The human pancreatic cancer cell lines PANC-1 and
As-PC-1 were purchased from the American Type Cul-
ture Collection. The cells were maintained in DMEM
media supplemented with 10% fetal bovine serum
(Gibco), 100 U/ml penicillin G (Invitrogen), and 0.1 mg/
ml streptomycin sulfate (Invitrogen) at 37°C in a hu-
midified, 5% CO2, 95% air atmosphere. This study was
approved by the Research Ethics Committee of Zheng-
zhou University, China.
RNA oligoribonucleotides and cell transfection
miR-337 mimics and the negative control (NC) were
chemically synthesized by Shanghai GenePharma Co. Ltd.
PANC- 1 and As-PC-1 cells were seeded in 6-well plates. A
final concentration of either 50 nM RNA mimics or NC
RNA was transfected into the cells using Lipofectamine™
2000 (Invitrogen) according to the manufacturer’s protocol.
Luciferase activity assay
The wild-type HOXB7 3′UTR luciferase reporter vector
(pmirGLO-HOXB7-WT) was constructed by amplifying
the human genomic DNA and then cloning it into the
Xbal site of pmirGLO-control vector. The primers used
were as follows: 5´ GGGATGGAGAAAGGGCAGAGG
AAGA 3´ (foward), 5´ GCTACAGAACAGGTAGATAA
TATCC 3´ (reverse). The mutant type HOXB7 3′UTR
luciferase reporter vector (pmirGLO-HOXB7-MUT) was
established using a site-directed mutagenesis kit (Pro-
mega) with pmirGLO-HOXB7-Wt serving as a template.miR-337 mimics or NC (final concentration, 50 nM),
100 ng luciferase reporter plasmid were cotransfected
into PANC-1 (or As-PC-1) cells of 90% confluence in
24-well plates. After 24 h, cells were lysed and luciferase
activity was measured using a Dual-Luciferase Reporter
Assay System (Promega).
Western blot
The cultured cells were lysed by using RIPA buffer. BCA
Protein Assay Kit was used to measure the protein
concentrations. The total protein was loaded onto 10%
SDS-PAGE gels and transferred to PVDF membranes.
Membranes were probed overnight at 4°C with antibody
recognizing HOXB7 (1:600, Santa Cruz), or GAPDH
(1:2000, Santa Cruz) in TBST containing 1% BSA (w/v).
Blots were then incubated for 2 h with anti-mouse sec-
ondary antibodies. Immune complexes were detected
using an ECL Plus Detection Kit (Pierce, Rockford, IL,
U.S.) and quantified using a scanning densitometer with
molecular analysis software (Bio-Rad, Hercules, CA, U.S.).
RNA extraction and qRT-PCR
Total RNA was isolated from cell lines using Trizol
(Invitrogen). The expression levels of mature miR-337 and
its precursor were quantified using quantitative real-time
PCR (qRT-PCR) using the TaqMan human microRNA
assay kits (Qiagen). U6 snRNA served as an internal nor-
malized reference. The relative expression ratio of miR-
337 was presented as the fold change as normalized to an
endogenous reference (U6 RNA) relative to the normal
cell line.
Cell counting kit-8 (CCK-8) assay
After transfection, cells were seeded in a 96-well plate at
a density of 1 × 104 cells per well and incubated for four
days. In vitro cell proliferation was evaluated using a
CCK-8 (Beyotime Inst Biotech, China) according to man-
ufacturer’s instructions. The absorbance was determined
at 450 nm wavelength with a reference wavelength of 630
nm. All experiments were performed in triplicate.
Colony formation assay
Twenty-four hours after RNA transfection, cells were
trypsinized and plated on 6-well plates (1000 cells/well)
and cultured of 2 weeks. Then the colonies were cap-
tured with the Olympus SZX12 and QCapture Pro soft-
ware. Cell colonies >0.1 mm in diameter were counted
under a microscope.
Wound healing assay
Cells (6 × 106 per well) at 12 h post-transfection were
seeded in six-well plates and allowed to adhere for
24 h. Confluent monolayer cells were scratched with a
200 μl pipette tip and then washed three times with
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serum-free medium was added, and the cells were
allowed to close the wound for 36 h. Photographs
were taken at 0 and 36 h at the same position relative
to the wound.Transwell invasion assay
The lower side and upper sides of separate polycarbon-
ate membranes (8 μm pores) of a transwell (Costar,
Lowell, MA, U.S.) were coated with Matrigel (80 μg/
well) for the invasion assays. The cells were added to
the upper chambers of a transwell; after incubation for
16 h at 37°C, the cells on the lower side were stained
with Giemsa stain. The level of invasion was determined
using a microscope at × 200 magnification. All experi-
ments were performed in triplicate.Statistical analysis
Statistical treatment was performed using SPSS 16.0 soft-
ware. One-way analysis of variance (ANOVA) and the χ2
test were used to analyze the significance between groups.
Multiple comparisons between the experimental group
and control groups were made using Tukey’s HSD when
the probability for ANOVA was statistically significant. All
data represent mean ± SD. The statistical significance was
set at P <0.05.Figure 1 HOXB7 is the target of miR-337. A) Sequence alignment of mi
prediction programs (miRBase, RNA22, miRanda, and TargetScan). B) Weste
PANC-1 and AsPC-1. The levels of HOXB7 protein were lower in cells transf
transfected with NC). C) There was significantly less relative luciferase activi
than in cells cotransfected with HOXB7-3′UTR-MUT and miR-337 mimics or
and NC. miR-337 mimics obviously inhibited luciferase activity in cells transResults
HOXB7 is the target of miR-337
Whether miR-337 affected the expression of HOXB7
protein was investigated by Western blot analysis. The
levels of HOXB7 protein were clearly lower in miR-337
overexpressing cells (PANC-1 and As-PC-1) than in con-
trol cells (Figure 1B). Four prediction programs (miRBase,
RNA22, miRanda, and TargetScan) were used to search
for potential miR-337 targets to characterize the mechan-
ism associated with miR-337 action. This analysis identi-
fied HOXB7 as a potential target of miR-337 (Figure 1A).
In order to further support these results, two reporter
plasmids carrying a wild-type HOXB7 3′UTR and a
mutant HOXB7 3′UTR, respectively, were constructed.
Cotransfection experiments showed that miR-337 mimics
obviously inhibited luciferase activity in cells transfected
with pmirGLO-HOXB7-WT but not in cells transfected
with pmirGLO-HOXB7-MUT. The inhibitory effect was
completely abrogated with pmirGLO-HOXB7-MUT,
which contained a mutation in the miR-337 binding site
(Figure 1C, D).miR-337 over-expression reduced tumor cell proliferation
CCK-8 for proliferation assay was performed for PANC-
1 and As-PC-1 cell lines, which were transfected with
either miR-337 mimics or NC. Marked inhibition of
growth was observed on the first day after transfection,R-337 and its target sites in 3′UTR of HOXB7 was revealed by four
rn blot was performed to detect the expression of HOXB7 protein in
ected with miR-337 mimics than in control cells (untransfected or
ty in cells cotransfected with HOXB7-3′UTR-WT and miR-337 mimics
in cells cotransfected with HOXB7-3′UTR-WT (or HOXB7-3′UTR-MUT)
fected with HOXB7-3′UTR-WT. Asterisks indicate significance at P <0.05.
Zhang et al. Diagnostic Pathology 2014, 9:171 Page 4 of 7
http://www.diagnosticpathology.org/content/9/1/171and a marked inhibitory effect on cell proliferation lasted
for four days (Figure 2A). The biological effect of miR-
337 mimics on anchorage-independent colony formation
in soft agar was also determined. After 2 weeks signifi-
cantly less (P < 0.05) PANC-1 (or As-PC-1) cells colony
forming potential was observed in cells treated with
miR-337 mimics than in the blank and negative control
groups, as assessed by the number of clones (Figure 2B).
miR-337 over-expression reduced tumor cell invasion
To evaluate the roles of miR-337 in the regulation of cell
mobility, the invasion ability of PANC-1 (or As-PC-1)
cells in vitro after different transfections was examined
using a wound healing assay and transwell invasion assay.
For a wound healing assay, PANC-1 (or As-PC-1) cells
transfected with miR-337 mimics at 36 h after incubation
exhibited a slower rate of invasion than that of miR-337
NC and untransfected group (Figure 3A). To further
evaluate the impact of miR-337 over-expression on cell in-
vasion, PANC-1 (or As-PC-1) cells were treated with the
different oligonucleotides and placed in a transwell cham-
ber. The numbers of miR-337-mimic-treated PANC-1 and
As-PC-1 cells invading through the Matrigel were signifi-
cantly lower (P < 0.05, P < 0.05) than in the blank controlFigure 2 miR-337 reduced cell proliferation in vitro. The effects of miR
in vitro were detected by CCK-8 assay and colony formation assay. A) After
were seeded in a 96-well plate and incubated for four days. CCK-8 assay sh
decreased compared to the control groups (NC and blank control) on days
were plated on 6-well plates and cultured of 2 weeks. A colony formation
significantly fewer colonies than the control groups (NC and blank control)and the NC groups (Figure 3B). These results demonstrate
that miR-337 over-expression inhibits the invasive ability
of PANC-1 and As-PC-1cells in vitro.
Discussion
Pancreatic cancer is one of the most common causes of
cancer-related death. It is a global public health problem.
Unfortunately, pancreatic cancer is highly aggressive,
highly metastatic and currently extremely difficult to diag-
nose. Because there are no effective therapeutic agents,
there is an urgent need to find and assess new ones.
HOX genes encode transcription factors that regulate
many vital processes, such as differentiation, apoptosis,
motility, angiogenesis, and receptor signaling. In adults,
few HOX genes are constitutively expressed any tissues
or organs, and most of them are silent [22,23]. Dysregula-
tion of HOX gene expression is common in human can-
cers. It has been shown that overexpression of HOXB7 is
involved in the differentiation, proliferation, and inva-
sion of many cancer cells in vitro [24–26]. Furthermore,
its overexpression was demonstrated to be closely re-
lated not only to the clinical invasive and aggressive
characteristics, such as high Dukes stage, T stage, dis-
tant metastasis-positive tumors, and high proliferation-337 mimics (or NC) on the proliferation of PANC-1 and As-PC-1 cells
transfection with miR-337 mimics (or NC), PANC-1 and As-PC-1cells
ows the absorbance of cells transfected with miR-337 mimics
0–4. B) Twenty-four hours after transfection, PANC-1 or As-PC-1cells
assay shows that cells transfected with miR-337 mimics formed
. Asterisks indicate significance at P < 0.05.
Figure 3 miR-337 reduced cell invasion in vitro. The effects of miR-337 mimics (or NC) on the proliferation of PANC-1 and As-PC-1 cells
in vitro were detected by wound healing assay and transwell invasion assay. A) PANC-1 and As-PC-1 cells at 12 h post-transfection were seeded
in six-well plates and cultured for 24 h. Confluent monolayer cells were scratched with a 200 μl pipette tip and were allowed to close the wound
for 36 h. Wound healing assays show the rate of invasion of PANC-1 (or As-PC-1) cells transfected with miR-337 mimics at 36 h were markedly
lower than in the control groups (blank control and cells transfected with miR-337 NC). B) The number of cells that migrate through the
Matrigel into the lower surface of the polycarbonic membrane was determined in a transwell invasion assay. Cell invasion was significantly less
pronounced in miR-337-mimic-treated cells than in the blank control and NC groups. Asterisks indicate significance at P < 0.05.
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[19,20,27].
In humans, miRNAs play important roles in cellular
physiology, development, and disease by negatively regu-
lating gene expression through translational repression or
post-transcriptional degradation [28]. miR-337 has been
reported to be expressed abnormally in many cancers
[29,30] such as breast cancer [31], esophageal squamous
cell carcinoma [32], and lung cancer [33]. Its expression
was found to be related to the survival of patients with
ovarian cancer [34] and gastric cancer [35]. Previous
studies showed that levels of miR-337 were low in hu-
man PDAC tissues, but levels of HOXB7 were high, and
there was a negative correlation (r = −0.719, P < 0.01)
between the level of HOXB7 mRNA and the level of
miR-337. In addition, expression of both was related to
TNM stage, lymph node status, and length of patient
survival. These data suggest that miR-337 is crucial to
the progression and metastasis of PDAC by regulating
the expression of HOXB7.
To provide further evidence that miR-337contributes
to the development of PDAC, two cancer cell lines, PANC-
1 and As-PC-1, were used to perform gain-of-function ex-
periments. PANC-1 cell line was started from a humanpancreatic carcinoma of a ductal cell origin, while As-PC-1
cell line was established from the ascites of a patient with
adenocarcinoma of the head of the pancreas. Morpho-
logically the two pancreatic tumor epithelioid cell lines
grow to confluency with moderately tight adhesion to
the culture plastic surface, and they are suitable trans-
fection hosts. PANC-1 and As-PC-1 were transfected
with miR-337 mimics, and the expression of HOXB7 pro-
tein was inhibited using Western blot analysis. Bioinfor-
matics analysis has also shown HOXB7 to be a potential
target of miR-337.
miRNAs regulate their target genes through the 3′UTR
of the gene. The 3′UTR of HOXB7 mRNA was linked to
the downstream of luciferase gene in pMIR reporter plas-
mid. In cells over-expressing miR-337, transfection of wild
HOXB7 luciferase reporter vector produced a significant
decrease in luciferase reporter gene activity, but no re-
duction was observed in the case of the mutant lucifer-
ase reporter gene. The luciferase activity assay further
confirmed that miR-337 regulates the expression of
HOXB7 by targeting its 3′UTR.
Upregulated expression of miR-337 was shown to sup-
press cell proliferation, invasion, and metastasis in PANC-
1 and As-PC-1. Results indicated that miR-337 could
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CCK-8 assay and in colony formation assay. Cell invasion
is a significant aspect of cancer progression. It involves the
migration of tumor cells into contiguous tissues and the
dissolution of extracellular matrix proteins. The weakened
invasive ability of cancer cells transfected with miR-337
mimics was observed in the wound healing and transwell
invasion assays. These results are consistent with the data
collected using clinical pancreatic cancer samples.
Conclusions
In summary, these results demonstrated that overexpres-
sion of miR-337 can suppress cell proliferation, migra-
tion, and invasion in human pancreatic cancer cell lines
by targeting HOXB7. These findings suggest that miR-
337 may play an important role in the development and
metastasis of PDAC. miR-337 may have therapeutic po-
tential for controlling or preventing PDAC progression
and metastasis.
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